nasdaq:srpt
|
617961
|
Apr 14th, 2024 12:00AM
|
Sarepta Therapeutics
|
99K
|
1393
|
Open
|
|
Apr 13th, 2024 11:44PM
|
Apr 13th, 2024 11:44PM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 13th, 2024 12:00AM
|
Sarepta Therapeutics
|
99K
|
1391
|
Open
|
|
Apr 12th, 2024 11:36PM
|
Apr 13th, 2024 12:09PM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 12th, 2024 12:00AM
|
Sarepta Therapeutics
|
99K
|
1391
|
Open
|
|
Apr 11th, 2024 11:43PM
|
Apr 12th, 2024 09:05AM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 11th, 2024 12:00AM
|
Sarepta Therapeutics
|
99K
|
1392
|
Open
|
|
Apr 11th, 2024 12:24AM
|
Apr 11th, 2024 11:50AM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 10th, 2024 12:00AM
|
Sarepta Therapeutics
|
98K
|
1393
|
Open
|
|
Apr 9th, 2024 11:44PM
|
Apr 10th, 2024 05:57PM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 9th, 2024 12:00AM
|
Sarepta Therapeutics
|
98K
|
1393
|
Open
|
|
Apr 8th, 2024 11:55PM
|
Apr 9th, 2024 10:39AM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 8th, 2024 12:00AM
|
Sarepta Therapeutics
|
98K
|
1392
|
Open
|
|
Apr 8th, 2024 12:35AM
|
Apr 8th, 2024 07:36PM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 7th, 2024 12:00AM
|
Sarepta Therapeutics
|
98K
|
1393
|
Open
|
|
Apr 6th, 2024 11:49PM
|
Apr 6th, 2024 11:49PM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 6th, 2024 12:00AM
|
Sarepta Therapeutics
|
98K
|
1391
|
Open
|
|
Apr 5th, 2024 11:49PM
|
Apr 5th, 2024 11:49PM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
617961
|
Apr 5th, 2024 12:00AM
|
Sarepta Therapeutics
|
98K
|
1392
|
Open
|
|
Apr 5th, 2024 12:39AM
|
Apr 5th, 2024 12:39AM
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
For information on our Community Guidelines, please visit sarepta.com/community-guidelines.
We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
|
Open
|
|
Open
|
215 First Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|